Boris Greber is an accomplished professional in the biopharmaceutical industry, currently serving as Managing Director and Head of R&D/iPSC Operations at Catalent Pharma Solutions since 2021. Previously, Boris held the position of Chief Scientific Officer and Head of Production at Rheincell Therapeutics GmbH from 2018 to 2021. Boris's earlier roles include Independent Research Group Leader at the Chemical Genomics Centre of the Max Planck Society (2012-2017), Senior Scientist and Project Group Leader at the Max-Planck-Institut für molekulare Biomedizin (2008-2012), and Postdoc at the Max-Planck-Institut für Molekulare Genetik (2001-2008). The academic journey concluded with a Dipl. Biochem. degree from the University of Potsdam from 1996 to 2000.
This person is not in any teams
This person is not in any offices